Hannah Mick, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-461-3877 |
Kami Sue Sisson, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 S Eisenhower Dr, Beckley, WV 25801 Phone: 304-256-7100 Fax: 304-256-7111 |
Mr. Eugene R Evans Ii, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 222 S Heber St, Beckley, WV 25801 Phone: 304-253-3471 |
Kenneth Onuorah, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-256-4100 |
Dr. William C. Boyd, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-255-2121 |
Michael Gray, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 Raleigh Ave, Beckley, WV 25801 Phone: 304-252-8324 |
Rickey Lee Bradley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4130 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-252-3900 Fax: 304-252-9311 |
James T Martin, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 201 Woodcrest Dr, Beckley, WV 25801 Phone: 304-250-0272 Fax: 304-250-0275 |
Dr. Nehal T Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 Harper Rd, Raleigh General Hospital, Beckley, WV 25801 Phone: 304-256-4076 Fax: 304-254-3002 |
Ashley Nichole Bradbury, Family Medicine - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 456 Cranberry Dr, Beckley, WV 25801 Phone: 304-255-6404 Fax: 304-255-6494 |
Dr. Christopher Gordon Edwards, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8555 |
Allie Caudill, Family Medicine Medicare: Medicare Enrolled Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8555 |
Caleb J Workman, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Community Health Systems Inc., 202 Bill Baker Way, Beckley, WV 25801 Phone: 304-252-8555 |
Dr. Tommy Lane Holbrook Ii, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Beckley Crossing Shpg Ctr, Beckley, WV 25801 Phone: 304-252-6639 |
Ida Z Villanueva, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8551 Fax: 304-252-1790 |
Nathaniel J Vangrouw, DO, RESIDENT Family Medicine Medicare: Medicare Enrolled Practice Location: 252 Rural Acres Dr, Beckley, WV 25801 Phone: 304-252-8555 |
Richard D Meadows, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 Woodcrest Dr, Beckley, WV 25801 Phone: 304-250-0272 Fax: 304-250-0275 |
Hannah Ariel Valentine, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800 |
Dr. Jeffrey Guy Harris, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 210 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800 Fax: 304-823-2703 |
Mr. John P Henderson Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 70 N Sturmer St, Belington, WV 26250 Phone: 304-823-2800 Fax: 304-823-2703 |
News Archive
Researchers from Durham University and Kings College London (United Kingdom) and the University of Erlangen-N-rnberg (Germany) found that patients who have suffered a subarachnoid hemorrhage (SAH) may not recover psychosocially as well as expected if their significant other is excessively fearful about the possibility of SAH recurrence.
A wave of recent research projects presented at the latest International PEEK Meeting in Washington, D.C., has highlighted the increasing adoption of PEEK implants in clinical practice as well as the materialĀ“s established position due to possible patient benefits.
MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).
Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for tafamidis meglumine, the company's investigational, novel, oral therapy for the treatment of Transthyretin Familial Amyloid Polyneuropathy.
› Verified 4 days ago